Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)
- Schneeweiss, A.
- Chia, S.
- Hickish, T.
- Harvey, V.
- Eniu, A.
- Hegg, R.
- Tausch, C.
- Seo, J.H.
- Tsai, Y.-F.
- Ratnayake, J.
- McNally, V.
- Ross, G.
- Cortés, J.
ISSN: 0923-7534, 1569-8041
Datum der Publikation: 2013
Ausgabe: 24
Nummer: 9
Seiten: 2278-2284
Art: Artikel